What is your preferred mode of vascular access for testicular cancer regimens?

Actually, we try to avoid all vascular access devices, especially PORT, which causes a 10-20% risk for clot as well as infection. These are young healthy patients usually with excellent veins. Over 90% of our large patient populations with testis cancer simply get their 5 days of chemo with a restar...

See our recent editorial "Once Upon a Time" published in J Clinical Oncology Practice. We go through the scant data available comparing peripheral versus central access for first-line therapy of germ cell tumors. I can say with a fair amount of confidence in these young healthy men, that pretty much...